Metric Finance
LearnFAQ
LearnFAQ

Learn / EOLS

NASDAQ: EOLS

Evolus (EOLS) stock, explained like you're 5

Evolus trades on the Nasdaq under the ticker EOLS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 511 million dollars.

Ticker
EOLS
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 511 million dollars

Is Evolus a small, medium or large cap company?

No. Evolus is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 511 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Evolus makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves EOLS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Evolus, Inc. (EOLS) stock price, news, quote and history (Yahoo Finance UK)
  • Bronstein, Gewirtz & Grossman, LLC Encourages Evolus, Inc. (EOLS) (The National Law Review)
  • Evolus, Inc. (EOLS) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program (Stock Titan)
  • EOLS270115C00005000 Interactive Stock Chart | EOLS Jan 2027 5.000 call Stock (Yahoo Finance)

Follow EOLS in your daily brief

Each trading day at 5 PM ET we post what happened to Evolus and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow EOLS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Evolus stock

What does Evolus do?

Evolus trades on the Nasdaq under the ticker EOLS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 511 million dollars.

What is the ticker symbol for Evolus?

Evolus trades under the ticker EOLS on the Nasdaq.

What is Evolus's market cap?

Evolus is a small cap stock with a market cap of about 511 million dollars.

How does Evolus make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves EOLS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow EOLS stock every day?

Add EOLS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow EOLS daily

A free brief on Evolus and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare EOLS: EOLS vs NVS, EOLS vs AZN, EOLS vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed